Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Ricarda Evens

17 indexed publications match this author name.

ORCID: 0000-0002-2834-2171
OpenAlex: https://openalex.org/A5054444045

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 8 Clinical Trial 6 Safety 6 Anxiety 4 Observational Study 4 Treatment-Resistant Depression 3 Adverse Events 3 Addiction 3 Creativity 3 Receptor Pharmacology 3 Review Article 2 Chronic Pain 2

Journals

Journal of psychopharmacology (Oxford, England) 2 PsyArXiv 2 Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 Neuroscience Applied 1 Current topics in behavioral neurosciences 1 Journal of Labelled Compounds and Radiopharmaceuticals 1 Cancer 1

Publication history

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 Landscape analysis of pre-registered clinical trials involving classical psychedelics.Journal of psychopharmacology (Oxford, England) · 2026-05-01 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2026-01-01 Classifying Psychedelic-Related Complications.Current topics in behavioral neurosciences · 2026-01-01 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01 The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22 The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22 Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01 Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.RSC medicinal chemistry · 2024-03-20 The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.Therapeutic advances in psychopharmacology · 2023-01-01 The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.Journal of psychopharmacology (Oxford, England) · 2022-03-01 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01 Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.Frontiers in psychiatry · 2020-01-01 Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.Experimental and clinical psychopharmacology · 2019-06-01 Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol useCurrent Opinion in Behavioral Sciences · 2016-11-14

Author directory